The AACR hosts a roundtable to ‘get real’ about cancer health disparities.

by Marci A. Landsmann

A higher proportion of cancer patients are enrolling in research studies than previously thought, but many patients lack the access needed to participate.

by Kyle Bagenstose

The drug showed promise in treating small cell lung cancer that had progressed during or after chemotherapy.

by Laura Gesualdi-Gilmore

FDA approval allows patients to collect samples for HPV test, lowering a barrier to an important cancer prevention tool.

by Taneia Surles

Facts and Stats

Decades of research and clinical trials led to CAR T-cell therapy becoming a critical blood cancer treatment.

by Thomas Celona

Immune checkpoint inhibitors are effective against non-small cell lung cancer in some patients. Researchers are investigating who benefits from the drugs and when they should be administered for maximum impact.

by Natalie Slivinski

With the FDA’s approval of the first tumor‑infiltrating lymphocyte (TIL) therapy to treat advanced melanoma, researchers seek to expand this type of cellular therapy to other solid tumors.

by Kendall K. Morgan

Forward Look

Oncologist and researcher Arjun Gupta discusses time toxicity and why it is important.

by Ashley P. Taylor

Forward Look

Research shows a scan can reveal treatment responses just one week after people with melanoma start immunotherapy.

by Anna Azvolinsky

Forward Look

Study suggests heated chemotherapy delivered to the abdominal cavity extends survival in advanced ovarian cancer.

by Kris Conner